Trials / Completed
CompletedNCT05741268
Effect of Dialectical Behavior in Patients With Bipolar Disorder
Effect of Dialectical Behavior Therapy on Emotion Regulation Difficulties, Distress Tolerance, and Social Functioning Among Patients With Bipolar Disorder: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- All
- Age
- 50 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study aims to: • Determine the effect of implementing Dialectical Behavior Therapy on emotion regulation difficulties, distress tolerance, and social functioning among patients with bipolar disorder. RESEARCH HYPOTHESIS Patients with bipolar disorder who are exposed to Dialectical Behavior Therapy will exhibit lower emotion regulation difficulties, distress tolerance, and higher social functioning than those who are not exposed to such training.
Detailed description
The researchers decided to work on a convenient sample of 30 adult patients with bipolar disorder. Dialectical behavior therapy will be applied through psychoeducation, discussion, rehearsal, and homework assignments. Four modules were administered in Mindfulness, Emotion Regulation, Emotion Regulation, and Emotion Regulation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Dialectical behavior therapy | 14\) Dialectical behavior therapy will be applied through psychoeducation, discussion, rehrasal and homework assignments. It contains four modules were administered in 14) Dialectical behavior therapy will be applied through psychoeducation, discussion, rehrasal and homework assignments. It contains four modules were administered in the following sequence 1. Mindfulness , 2. Emotion Regulation , 3. Distress Tolerance and 4. Interpersonal effectiveness. |
Timeline
- Start date
- 2023-03-02
- Primary completion
- 2023-07-15
- Completion
- 2023-09-10
- First posted
- 2023-02-23
- Last updated
- 2024-08-23
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05741268. Inclusion in this directory is not an endorsement.